Charles Duncan bought $38K of Vanda Pharmaceuticals stock
By AlphaYouPublished Form 4
Duncan Charles Cliff
Reporting filer
Charles Cliff Duncan reported buying 10,000 shares of Vanda Pharmaceuticals Inc. for about $38K ($3.81 a share on average). Form 4 filed Nov 5, 2026 lists 3 entries.
See the price move since this trade →
- Disclosed
- Nov 5, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Duncan Charles Cliff | 2026-11-03 | P | Purchase | 750 | 3.7959 | 99,451 | 2 days | Filed terms
|
| Common Stock | Duncan Charles Cliff | 2026-11-04 | P | Purchase | 3447 | 3.821 | 102,898 | 1 day | Filed terms
|
| Common Stock | Duncan Charles Cliff | 2026-11-05 | P | Purchase | 5803 | 3.8042 | 108,701 | 0 days | Filed terms
|
Common Stock
- Owner
- Duncan Charles Cliff
- Date
- 2026-11-03
- Code
- P
- Action
- Purchase
- Quantity
- 750
- Price
- 3.7959
- Following holdings
- 99,451
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-03
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: false
- transaction Shares: 750
- transaction Price Per Share: 3.7959
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 99451
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Duncan Charles Cliff
- Date
- 2026-11-04
- Code
- P
- Action
- Purchase
- Quantity
- 3447
- Price
- 3.821
- Following holdings
- 102,898
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-04
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: false
- transaction Shares: 3447
- transaction Price Per Share: 3.821
- id: F2
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 102898
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Duncan Charles Cliff
- Date
- 2026-11-05
- Code
- P
- Action
- Purchase
- Quantity
- 5803
- Price
- 3.8042
- Following holdings
- 108,701
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-05
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: false
- transaction Shares: 5803
- transaction Price Per Share: 3.8042
- id: F3
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 108701
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Duncan Charles Cliff: Director.
- F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.71 to $3.8389 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote (1) to this Form 4.
- F2: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.7799 to $3.89 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote (2) to this Form 4.
- F3: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.72 to $3.85 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote (3) to this Form 4.
Original sources
Prepared automatically from public filing data. Report a correction.